QT
BIIB icon

Quantamental Technologies’s Biogen BIIB Stock Holding History

Quantamental Technologies’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,316
Closed -$375K – 330
2023
Q2 		$375K Buy
+1,316
New +$392K 0.16% 222
2023
Q1 		– Sell
-3,271
Closed -$906K – 436
2022
Q4 		$906K Buy
3,271
+1,950
+148% +$551K 0.41% 68
2022
Q3 		$353K Buy
+1,321
New +$281K 0.14% 264
2021
Q4 		– Sell
-5,607
Closed -$1.59M – 390
2021
Q3 		$1.59M Buy
+5,607
New +$1.84M 1.06% 11
2020
Q4 		– Sell
-1,141
Closed -$324K – 113
2020
Q3 		$324K Sell
1,141
-2,854
-71% -$796K 0.24% 132
2020
Q2 		$1.07M Buy
3,995
+2,995
+300% +$900K 0.71% 36
2020
Q1 		$316K Sell
1,000
-3,449
-78% -$1.05M 0.74% 51
2019
Q4 		$1.32M Buy
4,449
+1,263
+40% +$350K 0.68% 16
2019
Q3 		$742K Buy
3,186
+1,189
+60% +$277K 0.24% 75
2019
Q2 		$467K Buy
1,997
+1,312
+192% +$303K 0.17% 155
2019
Q1 		$162K Sell
685
-516
-43% -$162K 0.07% 442
2018
Q4 		$361K Buy
+1,201
New +$383K 0.22% 100

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Quantamental Technologies's BIIB Position: Q3 2023 in Review

Quantamental Technologies sold out of Biogen (BIIB) in Q3 2023, closing a stake of 1,316 shares — an estimated $375K sold.

Quantamental Technologies first reported a position in BIIB in Q4 2018 and held it in 12 quarters. The position peaked at $1.59M in Q3 2021. 965 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

  • Quantamental Technologies reported no remaining Biogen position as of Q3 2023 after selling out during the quarter.
  • Quantamental Technologies sold 1,316 Biogen shares in Q3 2023, an estimated $375K.
  • Quantamental Technologies first reported a position in Biogen in Q4 2018 and held it in 12 quarters.
  • Quantamental Technologies's Biogen position peaked at $1.59M in Q3 2021.
  • 965 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.